Advertisement

Principles and practice of cadaver organ allocation in France

  • C. Jacquelinet
  • D. Houssin
Part of the Transplantation and Clinical Immunology book series (TRAC, volume 30)

Abstract

In France, as in many other countries around the world, progress in surgical procedures and immunosuppressive therapies, together with the success of transplantation programs, has resulted in an increased need of solid-organ supply [1]. Since most of the patients concerned are suffering from an endstage disease with a life-threatening functional organ failure, organ transplantation is a health-care response which takes place in a tragic context. Facing this need, the procurement of solid organs has been progressively reinforced, but has failed to cover the increase in demand [2, 3]. According to the data gathered by the Etablissement francais des Greffes (EfG), the 2807 solid-organ transplantations performed in France in 1996 are clearly less than the 4982 patients still registered on the national waiting list on 31 December 1995, and even less than the 3785 patients newly registered in the year 1996. Three hundred and forty-seven patients died while awaiting for a graft in 1996, and 740 patients were removed from the waiting list so that 4873 patients were still registered on the waiting list on 31 December 1996 [4].

Keywords

Brain Death Biliary Atresia Allocation Rule Allocation Policy Organ Procurement 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    First MR. Transplantation in the nineties. Transplantation. 1992; 53: 1–11.PubMedCrossRefGoogle Scholar
  2. 2.
    Houssin, D. Organ shortage: a public health crisis. What is the French state doing about it? Transplant. Proc. 1997; 29: 3197–3198.PubMedCrossRefGoogle Scholar
  3. 3.
    Spital A. The shortage of organs for transplantation: where do we go from here? N. Engl. J. Med. 1991; 325: 1243–1246.PubMedCrossRefGoogle Scholar
  4. 4.
    Le prelevement et la greffe en France en 1996. Rapport du Conseil Medical et Scientifique de l’Etablissement français des Greffes.Google Scholar
  5. 5.
    Terasaki PI, Cecka JM, Gjertson DW, Takemoto S. High survival rates of kidney transplants from spousal and living unrelated donors. N. Engl. J. Med. 1995; 333: 333–336.PubMedCrossRefGoogle Scholar
  6. 6.
    Orloff MS, Reed AI, Ertuk E et al. Nonheartbeating cadaver organ donation. Ann. Surg. 1994; 220: 578–583.PubMedCrossRefGoogle Scholar
  7. 7.
    Land W. The dilemna of organ allocation: the combination of a therapeutic modality for an ill individual with the distribution of a scarce valuable public (health) good. In: Collins GM, Dubernard JM, Land W, Persijn GG (eds.), Procurement, Preservation and Allocation of Vascularized Organs. Lancaster: Kluwer; 1997: 359–365.CrossRefGoogle Scholar
  8. 8.
    Hauptman PJ, O’Connor KJ. Procurement and allocation of solid organs for transplantation. N. Engl. J. Med. 1997; 336: 422–431.PubMedCrossRefGoogle Scholar
  9. 9.
    Persijn GG, Cohen B. Organ availability in Europe: problems and results. In: Collins GM, Dubernard JM, Land W, Persijn GG (eds.), Procurement, Preservation and Allocation of Vascularized Organs. Lancaster: Kluwer; 1997: 249–253.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media Dordrecht 1998

Authors and Affiliations

  • C. Jacquelinet
  • D. Houssin

There are no affiliations available

Personalised recommendations